165 related articles for article (PubMed ID: 26014912)
1. The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.
Wang JP; Yu YC; Chen SP; Liang HC; Lin CW; Fang K
Mol Cell Biochem; 2015 Sep; 407(1-2):123-33. PubMed ID: 26014912
[TBL] [Abstract][Full Text] [Related]
2. Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells.
Fang K; Chen SP; Lin CW; Cheng WC; Huang HT
Lung Cancer; 2009 Feb; 63(2):227-34. PubMed ID: 18619705
[TBL] [Abstract][Full Text] [Related]
3. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells.
Chang GC; Yu CT; Tsai CH; Tsai JR; Chen JC; Wu CC; Wu WJ; Hsu SL
Eur J Pharmacol; 2008 Dec; 600(1-3):37-44. PubMed ID: 18973751
[TBL] [Abstract][Full Text] [Related]
4. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
Wang F; Mao Y; You Q; Hua D; Cai D
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
[TBL] [Abstract][Full Text] [Related]
5. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
[TBL] [Abstract][Full Text] [Related]
6. p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer.
Rho JK; Choi YJ; Ryoo BY; Na II; Yang SH; Kim CH; Lee JC
Cancer Res; 2007 Feb; 67(3):1163-9. PubMed ID: 17283151
[TBL] [Abstract][Full Text] [Related]
7. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
Fraser M; Bai T; Tsang BK
Int J Cancer; 2008 Feb; 122(3):534-46. PubMed ID: 17918180
[TBL] [Abstract][Full Text] [Related]
8. An indolylquinoline derivative promotes apoptosis in human lung cancer cells by impairing mitochondrial functions.
Liu CY; Wu PT; Wang JP; Fan PW; Hsieh CH; Su CL; Chiu CC; Yao CF; Fang K
Apoptosis; 2015 Nov; 20(11):1471-82. PubMed ID: 26349782
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
Jin H; Qiao F; Wang Y; Xu Y; Shang Y
Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
[TBL] [Abstract][Full Text] [Related]
12. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
13. An α-quaternary chiral latam derivative, YH-304 as a novel broad-spectrum anticancer agent.
Hwang SJ; Park HG; Park Y; Lee HJ
Int J Oncol; 2016 Dec; 49(6):2480-2486. PubMed ID: 27748805
[TBL] [Abstract][Full Text] [Related]
14. A novel alkaloid, evodiamine causes nuclear localization of cytochrome-c and induces apoptosis independent of p53 in human lung cancer cells.
Mohan V; Agarwal R; Singh RP
Biochem Biophys Res Commun; 2016 Sep; 477(4):1065-1071. PubMed ID: 27402273
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells.
Kuo PL; Hsu YL; Chang CH; Lin CC
Cancer Lett; 2005 Jun; 223(2):293-301. PubMed ID: 15896464
[TBL] [Abstract][Full Text] [Related]
16. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
17. 5-Caffeoylquinic acid inhibits invasion of non-small cell lung cancer cells through the inactivation of p70S6K and Akt activity: Involvement of p53 in differential regulation of signaling pathways.
In JK; Kim JK; Oh JS; Seo DW
Int J Oncol; 2016 May; 48(5):1907-12. PubMed ID: 26984670
[TBL] [Abstract][Full Text] [Related]
18. Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
Savorani C; Manfé V; Biskup E; Gniadecki R
Leuk Lymphoma; 2015 Mar; 56(3):739-47. PubMed ID: 24898668
[TBL] [Abstract][Full Text] [Related]
19. Rescue of mutant p53 transcription function by ellipticine.
Peng Y; Li C; Chen L; Sebti S; Chen J
Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer.
Rajagopalan P; Alahmari KA; Elbessoumy AA; Balasubramaniam M; Suresh R; Shariff ME; Chandramoorthy HC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):393-404. PubMed ID: 26781309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
